Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Urinary Dysfunction in Myasthenic Syndromes: A Scoping Review of Clinical Features and Treatment-Related Associations.

Muscle & nerve·2026

Same author

Early Electroencephalographic Changes After Ketogenic Diet Initiation Are Associated With Clinical Response in Pediatric Drug-Resistant Epilepsy.

Seizure·2026

Same author

Evaluation of the effect of CFTR modulator therapy on lipid profiles in children.

Pediatric research·2026

Same author

The genetic landscape of childhood-onset dystonia in a nationwide Turkish cohort: Clinical spectrum, molecular diagnostics, and therapeutic implications.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026

Same author

A novel de novo CACNA1G variant p.(Arg1553Gln) associated with neurodevelopmental delay and cerebellar hypoplasia: Expanding the phenotypic spectrum.

European journal of medical genetics·2026

Same author

Eyes closed single-leg stance test detects subtle sensorimotor decline in early multiple sclerosis.

Scientific reports·2026

Search research articles

Related Experiment Video

Updated: Jul 28, 2025

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

Pediatric-Onset Chronic Inflammatory Demyelinating Polyneuropathy: A Multicenter Study.

Gamze Sarıkaya Uzan¹, Atay Vural², Deniz Yüksel³

¹Division of Child Neurology, Department of Pediatrics, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey.

Pediatric Neurology

|May 28, 2023

Summary

Pediatric chronic inflammatory demyelinating polyneuropathy (CIDP) treatment with intravenous immunoglobulin (IVIg) or IVIg plus steroids showed equal efficacy. MRI findings may correlate with clinical severity but not treatment response in pediatric CIDP patients.

Keywords:

Childhood Chronic inflammatory demyelinating polyneuropathy IVIg Immunotherapy Neurofascin antibodies Steroids

More Related Videos

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

Related Experiment Videos

Last Updated: Jul 28, 2025

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

Area of Science:

Neurology
Immunology
Pediatrics

Background:

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder affecting peripheral nerves.
Pediatric-onset CIDP presents unique diagnostic and therapeutic challenges.
Understanding the clinical and demographic features of pediatric CIDP is crucial for effective management.

Purpose of the Study:

To evaluate the clinical and demographic characteristics of pediatric-onset CIDP in Turkey.
To assess the efficacy of different treatment modalities for pediatric CIDP.
To investigate the association between MRI findings and clinical outcomes in pediatric CIDP.

Main Methods:

Retrospective review of clinical data from pediatric CIDP patients (2010-2021).
Evaluation based on the 2021 Joint Task Force Guideline for CIDP management.
Comparison of treatment outcomes between intravenous immunoglobulin (IVIg) monotherapy and IVIg plus steroid combination therapy.
Analysis of magnetic resonance imaging (MRI) characteristics and their correlation with clinical severity.

Main Results:

A total of 43 pediatric patients (51.2% male) were included.
Significant improvement in modified Rankin scale (mRS) scores was observed post-treatment for all patients.
First-line treatments (IVIg vs. IVIg + steroids) showed comparable efficacy (P > 0.05).
Abnormal MRI findings were associated with higher pretreatment mRS scores (P < 0.05).

Conclusions:

First-line immunotherapy, including IVIg and IVIg plus steroids, demonstrated equal efficacy in treating pediatric CIDP.
MRI features may be linked to disease severity but do not appear to influence treatment response in pediatric CIDP.